A Dual-Action Liposome-Peptide Formulation Synergistically Counteracts A Gain-of-Function p53 Mutant
Sneha Ghosh Chaudhary, Swati Bhowmick, Samriddhi Bhattacharya, Siddhartha Roy, Nahid Ali
This paper develops a liposome-peptide formulation that enhances doxorubicin's effectiveness against p53R273H mutant tumors by disrupting PC4 interaction.
bioRxiv · Apr 9, 2025 · PreprintCancer Biology